At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HSDT Helius Medical Technologies, Inc.
Post-Market Trading 11-22 18:14:58 EST
0.4532
+0.0230
+5.35%
盘后0.4500
-0.0032-0.71%
16:02 EST
High0.5100
Low0.4500
Vol265.21K
Open0.4630
D1 Closing0.4302
Amplitude13.95%
Mkt Cap1.62M
Tradable Cap1.61M
Total Shares3.58M
T/O131.26K
T/O Rate7.46%
Tradable Shares3.56M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Helius Medical Technologies Inc reports results for the quarter ended September 30 - Earnings Summary
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.